Search Results - "Rüther, E."

Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin by EHRENREICH, H, HINZE-SELCH, D, RITZEN, M, MOHR, A, WAGNER, M, SCHNEIDER, U, BOHN, M, HUBER, M, CZERNIK, A, POLLMÄCHER, T, MAIER, W, SIREN, A-L, STAWICKI, S, KLOSTERKÖTTER, J, FALKAI, P, RÜTHER, E, ALDENHOFF, J. B, KRAMPE, H, AUST, C, KNOLLE-VEENTJER, S, WILMS, S, HEINZ, G, ERDAG, S, JAHN, H, DEGNER, D

“…Schizophrenia is increasingly recognized as a neurodevelopmental disease with an additional degenerative component, comprising cognitive decline and loss of…”
Get full text

Genome-wide significant risk factors for Alzheimer’s disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment by Lacour, A, Espinosa, A, Louwersheimer, E, Heilmann, S, Hernández, I, Wolfsgruber, S, Fernández, V, Wagner, H, Rosende-Roca, M, Mauleón, A, Moreno-Grau, S, Vargas, L, Pijnenburg, Y A L, Koene, T, Rodríguez-Gómez, O, Ortega, G, Ruiz, S, Holstege, H, Sotolongo-Grau, O, Kornhuber, J, Peters, O, Frölich, L, Hüll, M, Rüther, E, Wiltfang, J, Scherer, M, Riedel-Heller, S, Alegret, M, Nöthen, M M, Scheltens, P, Wagner, M, Tárraga, L, Jessen, F, Boada, M, Maier, W, van der Flier, W M, Becker, T, Ramirez, A, Ruiz, A

“…Few data are available concerning the role of risk markers for Alzheimer’s disease (AD) in progression to AD dementia among subjects with mild cognitive…”
Get full text

History, background, concepts and current use of comedication and polypharmacy in psychiatry by Möller, H.-J., Seemüller, F., Schennach-Wolff, R., Stübner, S., Rüther, E., Grohmann, R.

“…Based on a careful literature search a review is presented of the history, background, concepts and current use of comedication and polypharmacy in psychiatry…”
Get full text

Seizures during antidepressant treatment in psychiatric inpatients—results from the transnational pharmacovigilance project “Arzneimittelsicherheit in der Psychiatrie” (AMSP) 1993–2008 by Köster, M., Grohmann, R., Engel, R. R., Nitsche, M. A., Rüther, E., Degner, D.

“…Rationale There is little clinical data available about seizure rates in psychiatric inpatients, and there are no studies with reference data to the…”
Get full text

Erythropoietin: a candidate compound for neuroprotection in schizophrenia by EHRENREICH, H, DEGNER, D, VON AHSEN, N, MAIER, W, BRÜCK, W, RÜTHER, E, CERAMI, A, BECKER, W, SIREN, A.-L, MELLER, J, BRINES, M, BEHE, M, HASSELBLATT, M, WOLDT, H, FALKAI, P, KNERLICH, F, JACOB, S

“…Erythropoietin (EPO) is a candidate compound for neuroprotection in human brain disease capable of combating a spectrum of pathophysiological processes…”
Get full text

Validation of amyloid-β peptides in CSF diagnosis of neurodegenerative dementias by BIBL, M, MOLLENHAUER, B, WILTFANG, J, LEWCZUK, P, ESSELMANN, H, WOLF, S, TRENKWALDER, C, OTTO, M, STIENS, G, RÜTHER, E, KORNHUBER, J

“…Biomarkers for differential diagnosis of the three most frequent degenerative forms of dementia, Alzheimer's disease (AD), dementia with Lewy bodies (DLB) and…”
Get full text

Highly conserved and disease‐specific patterns of carboxyterminally truncated Aβ peptides 1–37/38/39 in addition to 1–40/42 in Alzheimer's disease and in patients with chronic neuroinflammation by Wiltfang, J., Esselmann, H., Bibl, M., Smirnov, A., Otto, M., Paul, S., Schmidt, B., Klafki, H.‐W., Maler, M., Dyrks, T., Bienert, M., Beyermann, M., Rüther, E., Kornhuber, J.

“…Human lumbar CSF patterns of Aβ peptides were analysed by urea‐based β‐amyloid sodium dodecyl sulphate polyacrylamide gel electrophoresis with western…”
Get full text

Correction to: Assessment of Psychosocial Functioning in a Large Cohort of Patients with Schizophrenia by Kossmann, C., Heller, J., Brüne, M., Schulz, C., Heinze, M., Cordes, J., Mühlbauer, B., Rüther, E., Timm, J., Gründer, G., Juckel, G.

Get full text

Assessment of Psychosocial Functioning in a Large Cohort of Patients with Schizophrenia by Kossmann, C., Heller, J., Brüne, M., Schulz, C., Heinze, M., Cordes, J., Mühlbauer, B., Rüther, E., Timm, J., Gründer, G., Juckel, G.

“…Background This study addresses the question of whether psychosocial functioning measured by the Personal and Social Performance (PSP) Scale is related to…”
Get full text

Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome by Jordan, W, Cohrs, S, Degner, D, Meier, A, Rodenbeck, A, Mayer, G, Pilz, J, Rüther, E, Kornhuber, J, Bleich, S

“…Assessment of reactive oxygen species (ROS) is highly important in neurodegenerative disorders and neuroleptic treatment. However, conflicting results have…”
Get full text

Amyloid β peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing by Lewczuk, P., Kornhuber, J., Vanmechelen, E., Peters, O., Heuser, I., Maier, W., Jessen, F., Bürger, K., Hampel, H., Frölich, L., Henn, F., Falkai, P., Rüther, E., Jahn, H., Luckhaus, Ch, Perneczky, R., Schmidtke, K., Schröder, J., Kessler, H., Pantel, J., Gertz, H.-J., Vanderstichele, H., de Meyer, G., Shapiro, F., Wolf, S., Bibl, M., Wiltfang, J.

“…We measured concentrations of Aβ peptides 1–42 and 1–40, and their ratio in plasma of patients carefully categorized clinically and neurochemically as having…”
Get full text

The sleep-improving effects of doxepin are paralleled by a normalized plasma cortisol secretion in primary insomnia: A placebo-controlled, double-blind, randomized, cross-over study followed by an open treatment over 3 weeks by RODENBECK, A, COHRS, S, JORDAN, W, HUETHER, G, RÜTHER, E, HAJAK, G

“…In primary care, sedating antidepressants are often used for treating insomnia, although their underlying sleep-promoting mechanisms are only incompletely…”
Get full text

Flupentixol use and adverse reactions in comparison with other common first- and second-generation antipsychotics: data from the AMSP study by Grohmann, R., Engel, R. R., Möller, H.-J., Rüther, E., van der Velden, J. W., Stübner, S.

“…This study compares the first-generation antipsychotic (FGA) flupentixol to haloperidol and common second-generation antipsychotics (SGAs) as to drug…”
Get full text

Doxepin in the treatment of primary insomnia : A placebo-controlled, double-blind, polysomnographic study by HAJAK, Goran, RODENBECK, Andrea, VODERHOLZER, Ulrich, RIEMANN, Dieter, COHRS, Stefan, HOHAGEN, Fritz, BERGER, Mathias, RÜTHER, Eckart

“…Over recent years, the use of antidepressants for the symptomatic treatment of insomnia has grown substantially, but controlled studies are still lacking. Our…”
Get full text

Photo-illuminated diamond as a solid-state source of solvated electrons in water for nitrogen reduction by Zhu, Di, Zhang, Linghong, Ruther, Rose E., Hamers, Robert J.

“…The photocatalytic reduction of N 2 to NH 3 is typically hampered by poor binding of N 2 to catalytic materials and by the very high energy of the…”
Get full text

The AMSP drug safety program: methods and global results by Grohmann, R, Engel, R R, Rüther, E, Hippius, H

“…The AMSP (Arzneimittelsicherheit in der Psychiatry) study is a drug safety program that ensures the continuous assessment of severe adverse drug reactions…”
Get more information

Identifying the limiting electrode in lithium ion batteries for extreme fast charging by Mao, Chengyu, Ruther, Rose E., Li, Jianlin, Du, Zhijia, Belharouak, Ilias

“…Lithium ion batteries that are capable of extreme fast charging (XFC) are highly desirable to accelerate adoption of electric vehicles (EVs). To identify the…”
Get full text

What are depressive symptoms in acutely ill patients with schizophrenia spectrum disorder? by Schennach, R, Riedel, M, Obermeier, M, Seemüller, F, Jäger, M, Schmauss, M, Laux, G, Pfeiffer, H, Naber, D, Schmidt, L.G, Gaebel, W, Klosterkötter, J, Heuser, I, Maier, W, Lemke, M.R, Rüther, E, Klingberg, S, Gastpar, M, Möller, H.-J

“…Abstract Background Aim was to examine depressive symptoms in acutely ill schizophrenia patients on a single symptom basis and to evaluate their relationship…”
Get full text

Evaluating depressive symptoms and their impact on outcome in schizophrenia applying the Calgary Depression Scale by Schennach-Wolff, R., Obermeier, M., Seemüller, F., Jäger, M., Messer, T., Laux, G., Pfeiffer, H., Naber, D., Schmidt, L. G., Gaebel, W., Klosterkötter, J., Heuser, I., Maier, W., Lemke, M. R., Rüther, E., Klingberg, S., Gastpar, M., Möller, H.-J., Riedel, M.

“…Schennach‐Wolff R, Obermeier M, Seemüller F, Jäger M, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke…”
Get full text

Severe and uncommon involuntary movement disorders due to psychotropic drugs by Stübner, S, Rustenbeck, E, Grohmann, R, Wagner, G, Engel, R, Neundörfer, G, Möller, H-J, Hippius, H, Rüther, E

“…Disorders of involuntary movement due to psychotropic drugs pose a major problem when treating mentally ill patients. These adverse drug reactions (ADR)…”
Get more information